News
News Center
2022-02-11
We look forward to scientists conducting more extensive, large-scale clinical studies and trials on stem cells, further exploring and unlocking their medical potential—so that more patients with spinal cord injuries can truly benefit.
+
2022-02-09
Hot topics include: organoids, organ-on-a-chip systems, extracellular vesicles (exosomes), stem cells and organ anti-aging, in situ organ regeneration, and stem cells combined with biomaterials.
+
2022-01-26
Two national ministries jointly issued a document: easing market access restrictions in Shenzhen's pharmaceutical sector, and supporting the development of innovative medical products and technologies such as stem-cell therapies and immunotherapies!
+
2022-01-19
This special support program includes two key components: a major public service platform for the biopharmaceutical industry and a core technology research initiative, as well as a city-level public technical service platform upgrade program. Under the program, up to 300 million yuan in funding is available for tackling critical core technologies.
+
2022-01-18
Provincial Political Consultative Conference members Wu Jinming, Kong Heping, Chen Hongzhong, and Zheng Ansheng jointly proposed that Hunan should follow the practices of cities like Tianjin and Shenzhen, granting clinical institutions within the free trade zone permission to carry out clinical applications of stem-cell therapies as well as charge cost-based fees.
+
2022-01-11
Jiuzhitang Maker wins two major awards at the "2021 Brand Powerhouse Economic Forum (5th Edition)"
On January 7, 2022, the "2021 Brand Power Economic Forum & (5th) Innovation Achievement Promotion Event" was held in Hainan. Jiuzhitang Maker was invited to attend and proudly won two prestigious awards: "2021 Innovation China – Top 100 Innovative Enterprises" and "2021 Brand Power – Top 10 Innovative Enterprises in the Biopharmaceutical Industry."
+
2022-01-10
On January 6, 2022, to implement the "Drug Administration Law of the People's Republic of China," the National Medical Products Administration (NMPA) publicly released the draft "Appendix to the Pharmaceutical Production Quality Management Regulations—Cell Therapy Products" for public comment through its Comprehensive Department, inviting input from society.
+
2022-01-05
TED Talk: The Future of Medicine—Healing with Cells, Not Pills!
The future of medicine will transform the way we treat diseases. Soon, we’ll be using cell-based therapies instead of pills.
+
Here is the title—h1 placeholder text
Copyright © Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd.
Powered by: 300.cn SEO | Privacy Policy